Staphylococcus aureus 4-Antigen (SA4Ag) Vaccine
Phase 2Terminated 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Staphylococcal Vaccine
Conditions
Staphylococcal Vaccine
Trial Timeline
Jul 2, 2015 → Jun 27, 2019
NCT ID
NCT02388165About Staphylococcus aureus 4-Antigen (SA4Ag) Vaccine
Staphylococcus aureus 4-Antigen (SA4Ag) Vaccine is a phase 2 stage product being developed by Pfizer for Staphylococcal Vaccine. The current trial status is terminated. This product is registered under clinical trial identifier NCT02388165. Target conditions include Staphylococcal Vaccine.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02388165 | Phase 2 | Terminated |
Competing Products
20 competing products in Staphylococcal Vaccine